Feature|Articles|September 12, 2023
- Pharmaceutical Executive: September 2023
- Volume 43
- Issue 9
Pharmaceutical Executive, September 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive September 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
A New Era of Ethical Leadershipabout 2 years ago
Ahead of the Curve: Pharm Exec Profiles Five Recent Drug Launchesabout 2 years ago
Survival Story: Enhertuabout 2 years ago
Gut Instinct: Rebyotaabout 2 years ago
Delaying Disease Onset: Tzieldabout 2 years ago
New Beginnings: Sunlencaabout 2 years ago
A Heartfelt Solution: Camzyosabout 2 years ago
Fortifying Defenses Pre-Patent Cliffabout 2 years ago
New Product Planning: The Function's Evolution in Pharmaabout 2 years ago
No Rate Relief in Sight for BiotechNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
2
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
3
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
4
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
5
